Thompson Siegel & Walmsley’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
DRZID
Thompson Siegel & Walmsley's OGN Position: Q1 2025 in Review
Thompson Siegel & Walmsley sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 208,808 shares — an estimated $3.12M sold.
Thompson Siegel & Walmsley first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $88.7M in Q4 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q1 2025.
- Thompson Siegel & Walmsley reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
- Thompson Siegel & Walmsley sold 208,808 Organon & Co shares in Q1 2025, an estimated $3.12M.
- Thompson Siegel & Walmsley first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
- Thompson Siegel & Walmsley's Organon & Co position peaked at $88.7M in Q4 2021.
- 719 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.
Based on Thompson Siegel & Walmsley's 13F filing for Q1 2025, filed 9 May 2025.